Table of Contents
ISRN Obstetrics and Gynecology
Volume 2011, Article ID 950460, 6 pages
http://dx.doi.org/10.5402/2011/950460
Clinical Study

Endometrial Cancer Patients: A Cohort Previous to Changes in Tumour Behaviour and Treatment Strategies

Department of Obstetrics and Gynecology, Orbis Medical Centre, Postbus 5500, 6130MB Sittard, The Netherlands

Received 20 July 2011; Accepted 1 September 2011

Academic Editors: V. Anaf and S. Palomba

Copyright © 2011 F. K. L. Tournois and H. J. M. M. Mertens. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” Ca-A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Google Scholar
  2. Dutch cancer registration, 2008, http://www.ikcnet.nl/uploaded/docs/Landelijk/cijfers/incidentie%202008/A04_NL.xls.
  3. Dutch cancer registration, 2008, http://www.ikcnet.nl/uploaded/docs/Landelijk/cijfers/incidentie%202008/B1_NL.xls.
  4. P. Uharček, “Prognostic factors in endometrial carcinoma,” Journal of Obstetrics and Gynaecology Research, vol. 34, no. 5, pp. 776–783, 2008. View at Publisher · View at Google Scholar
  5. C. L. Kosary, “FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973–87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina,” Seminars in Surgical Oncology, vol. 10, no. 1, pp. 31–46, 1994. View at Google Scholar
  6. W. Creasman, “Revised FIGO staging for carcinoma of the endometrium,” International Journal of Gynecology and Obstetrics, vol. 105, no. 2, p. 109, 2009. View at Publisher · View at Google Scholar · View at PubMed
  7. S. Pecorelli, “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium,” International Journal of Gynaecology and Obstetrics, vol. 105, no. 2, pp. 103–104, 2009. View at Google Scholar
  8. O. Devaja, I. Samara, and A. J. Papadopoulos, “Laparoscopically assisted vaginal hysterectomy (LAVH) versus total abdominal hysterectomy (TAH) in endometrial carcinoma: prospective cohort study,” International Journal of Gynecological Cancer, vol. 20, no. 4, pp. 570–575, 2010. View at Publisher · View at Google Scholar · View at PubMed
  9. Z. Holub, A. Jabor, P. Bartos, J. Eim, Š. Urbánek, and R. Pivovarniková, “Laparoscopic surgery for endometrial cancer: long-term results of a multicentric study,” European Journal of Gynaecological Oncology, vol. 23, no. 4, pp. 305–310, 2002. View at Google Scholar
  10. I. Kalogiannidis, S. Lambrechts, F. Amant, P. Neven, T. V. Gorp, and I. Vergote, “Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome,” American Journal of Obstetrics and Gynecology, vol. 196, no. 3, pp. 248–e1, 2007. View at Publisher · View at Google Scholar · View at PubMed
  11. M. J. E. Mourits, C. B. Bijen, H. J. Arts et al., “Safety of laparoscopy versus laparotomy in early-stage endometrial cancer: a randomised trial,” The Lancet Oncology, vol. 11, no. 8, pp. 763–771, 2010. View at Publisher · View at Google Scholar
  12. F. Zullo, S. Palomba, A. Falbo et al., “Laparoscopic surgery vs laparotomy for early stage endometrial cancer: long-term data of a randomized controlled trial,” American Journal of Obstetrics and Gynecology, vol. 200, no. 3, pp. 296.e1–296.e9, 2009. View at Publisher · View at Google Scholar · View at PubMed
  13. C. L. Creutzberg, W. L. Van Putten, P. C. Koper et al., “Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial,” The Lancet, vol. 355, no. 9213, pp. 1404–1411, 2000. View at Google Scholar
  14. National guideline endometrial carcinoma, Dutch cancer centre, 2008, http://www.oncoline.nl/endometriumcarcinoom.
  15. F. Bray, I. Dos Santos Silva, H. Moller, and E. Weiderpass, “Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1132–1142, 2005. View at Publisher · View at Google Scholar · View at PubMed
  16. W. Creasman, F. Odicino, P. Maisonneuve et al., “Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological,” International Journal of Gynecology and Obstetrics, vol. 95, supplement 1, pp. S105–S143, 2006. View at Publisher · View at Google Scholar · View at PubMed
  17. S. Siesling, J. A. A. M. Van Dijck, O. Visser, and J. W. W. Coebergh, “Trends in incidence of and mortality from cancer in The Netherlands in the period 1989–1998,” European Journal of Cancer, vol. 39, no. 17, pp. 2521–2530, 2003. View at Publisher · View at Google Scholar
  18. I. M. Kellert, A. A. M. Botterweck, J. A. M. Huveneers, and M. J. M. Dirx, “Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986–2003,” European Journal of Cancer Prevention, vol. 18, no. 1, pp. 85–89, 2009. View at Publisher · View at Google Scholar · View at PubMed
  19. J. I. Sorosky, “Endometrial cancer,” Obstetrics and Gynecology, vol. 111, no. 2, pp. 436–447, 2008. View at Publisher · View at Google Scholar · View at PubMed
  20. J. W. Kim, S. H. Kim, Y. T. Kim, and D. K. Kim, “Clinicopathologic and biological parameters predicting the prognosis in endometrial cancer,” Yonsei Medical Journal, vol. 43, no. 6, pp. 769–778, 2002. View at Google Scholar
  21. T. O. Kirby, C. A. Leath, and L. C. Kilgore, “Surgical staging in endometrial cancer,” Oncology, vol. 20, no. 1, pp. 45–50, 2006. View at Google Scholar
  22. J. S. Kwon, M. Mazgani, D. M. Miller et al., “The significance of surgical staging in intermediate-risk endometrial cancer,” Gynecologic Oncology, vol. 122, no. 1, pp. 50–54, 2011. View at Publisher · View at Google Scholar · View at PubMed
  23. C. V. Lutman, L. J. Havrilesky, J. M. Cragun et al., “Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology,” Gynecologic Oncology, vol. 102, no. 1, pp. 92–97, 2006. View at Publisher · View at Google Scholar · View at PubMed
  24. N. Sirisabya, T. Manchana, P. Worasethsin et al., “Is complete surgical staging necessary in clinically early-stage endometrial carcinoma?” International Journal of Gynecological Cancer, vol. 19, no. 6, pp. 1057–1061, 2009. View at Publisher · View at Google Scholar · View at PubMed
  25. C. L. Creutzberg, R. A. Nout, M. L. Lybeert et al., “Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for Endometrial Carcinoma,” International Journal of Radiation Oncology Biology Physics, vol. 81, no. 4, pp. e631–e638, 2011. View at Publisher · View at Google Scholar · View at PubMed
  26. R. A. Nout, V. T. H. B. M. Smit, H. Putter et al., “Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial,” The Lancet, vol. 375, no. 9717, pp. 816–823, 2010. View at Publisher · View at Google Scholar
  27. A. Alvarez Secord, L. J. Havrilesky, V. Bae-Jump et al., “The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer,” Gynecologic Oncology, vol. 107, no. 2, pp. 285–291, 2007. View at Publisher · View at Google Scholar · View at PubMed
  28. C. L. Creutzberg, “Adjuvant chemotherapy for endometrial cancer: unproven,” International Journal of Gynecological Cancer, vol. 20, no. 7, pp. 1105–1108, 2010. View at Publisher · View at Google Scholar
  29. K. Greven, K. Winter, K. Underhill, J. Fontenesci, J. Cooper, and T. Burke, “Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer,” Gynecologic Oncology, vol. 103, no. 1, pp. 155–159, 2006. View at Publisher · View at Google Scholar · View at PubMed
  30. T. Hogberg, M. Signorelli, C. F. De Oliveira et al., “Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer-Results from two randomised studies,” European Journal of Cancer, vol. 46, no. 13, pp. 2422–2431, 2010. View at Publisher · View at Google Scholar · View at PubMed
  31. P. J. Hoskins, K. D. Swenerton, J. A. Pike et al., “Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study,” Journal of Clinical Oncology, vol. 19, no. 20, pp. 4048–4053, 2001. View at Google Scholar
  32. T. Kuoppala, J. Mäenpää, E. Tomas et al., “Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy,” Gynecologic Oncology, vol. 110, no. 2, pp. 190–195, 2008. View at Publisher · View at Google Scholar · View at PubMed
  33. C. P. Morrow, B. N. Bundy, H. D. Homesley et al., “Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study,” Gynecologic Oncology, vol. 36, no. 2, pp. 166–171, 1990. View at Publisher · View at Google Scholar
  34. K. Nakayama, Y. Nagai, M. Ishikawa, Y. Aoki, and K. Miyazaki, “Concomitant postoperative radiation and chemotherapy following surgery was associated with improved overall survival in patients with FIGO stages III and IV endometrial cancer,” International Journal of Clinical Oncology, vol. 15, no. 5, pp. 440–446, 2010. View at Publisher · View at Google Scholar · View at PubMed
  35. S. A. Scudder, P. Y. Liu, S. P. Wilczynski et al., “Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group,” Gynecologic Oncology, vol. 96, no. 3, pp. 610–615, 2005. View at Publisher · View at Google Scholar · View at PubMed
  36. D. Boll, R. H. Verhoeven, M. A. Van Der Aa, M. L. Lybeert, J. W. Coebergh, and M. L. Janssen-Heijnen, “Adherence to national guidelines for treatment and outcome of endometrial cancer stage i in relation to co-morbidity in southern Netherlands 1995–2008,” European Journal of Cancer, vol. 47, no. 10, pp. 1504–1510, 2011. View at Publisher · View at Google Scholar · View at PubMed